Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care Journal:Asia-Pacific Journal of Clinical Oncology | 2021 | ||
Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer Journal:Asia-Pacific Journal of Clinical Oncology | 2020 |